Gabinet Endoskopii Przewodu Pokarmowego
- Address
- ul. Szewska 4/5, 31-009 Krakow, Poland
Gabinet Endoskopii Przewodu Pokarmowego - Inflammatory Bowel Disease Research Center
Gabinet Endoskopii Przewodu Pokarmowego is a specialized endoscopy center with demonstrated expertise in gastroenterological research, particularly focusing on inflammatory bowel diseases. The center's research portfolio emphasizes advanced therapeutic strategies and treatment optimization for patients with complex gastrointestinal conditions, utilizing state-of-the-art endoscopic evaluation techniques to assess disease activity and treatment response.
- Long-term biologic therapy studies for ulcerative colitis, including novel IL-23 inhibitors
- Treatment target optimization and treat-to-target strategies in inflammatory bowel disease
- Comprehensive disease assessment combining symptomatic, endoscopic, and histological endpoints
The center's research emphasizes achieving deep remission in ulcerative colitis patients through multi-dimensional treatment targets. Their participation in extension studies demonstrates commitment to evaluating long-term safety and efficacy of emerging therapies. The facility's focus on corticosteroid-free remission and prevention of UC-related complications reflects a patient-centered approach to optimizing disease management and improving long-term clinical outcomes in inflammatory bowel disease populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1F. Hoffmann-La Roche AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gabinet Endoskopii Przewodu Pokarmowego
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomized, double-blind, multicenter phase 3 study in patients with moderately to severely active ulcerative colitis (UC) to compare the efficacy, safety and immunogenicity of PB016 and Entyvio® for the induction and maintenance of clinical response and remission. (UCESIVE) | Polpharma Biologics S.A. | Phase III | Not Recruiting | Nov 2023 | Apr 2026 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Vedolizumab | 2 | Unknown | 2021-01-15 | 2023-11-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.